Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reck

Showing results (891-900 of 1,518) with videos related to

Pageof 152
Sort By:
Lung Cancer (Amsterdam, Netherlands)|October 24, 2013
A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancerMartin Reck, Maciej Krzakowski, Ewa Chmielowska, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2012
Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trialM Reck, I Bondarenko, A Luft, et al.
Lung Cancer (Amsterdam, Netherlands)|January 28, 2014
Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)N Reinmuth, A Meyer, D Hartwigsen, et al.
Nature Communications|April 29, 2022
Mitofusin 1 and 2 regulation of mitochondrial DNA content is a critical determinant of glucose homeostasisVaibhav Sidarala, Jie Zhu, Elena Levi-D'Ancona, et al.
Nature Structural & Molecular Biology|May 23, 2025
Multiple steps of dynein activation by Lis1 visualized by cryo-EMAgnieszka A Kendrick, Kendrick H V Nguyen, Wen Ma, et al.
Oncology|January 25, 2012
A phase II randomized study of cisplatin-pemetrexed plus either enzastaurin or placebo in chemonaive patients with advanced non-small cell lung cancerJohan Vansteenkiste, Rodryg Ramlau, Joachim von Pawel, et al.
Glycoconjugate Journal|June 1, 1995
Substrate specificity and inhibition of UDP-GlcNAc:GlcNAc beta 1-2Man alpha 1-6R beta 1,6-N-acetylglucosaminyltransferase V using synthetic substrate analoguesI Brockhausen, F Reck, W Kuhns, et al.
Clinical Lung Cancer|March 26, 2017
The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613Jordi Remon, Jessica Menis, Baktiar Hasan, et al.
Microorganisms|November 24, 2022
Bioremediation of Petroleum-Contaminated Soils with Biosurfactant-Producing Degraders Isolated from the Native Desert SoilsZheng Li, Ravid Rosenzweig, Fengxian Chen, et al.
Cerebral Cortex (New York, N.Y. : 1991)|June 5, 2013
Dopamine replacement modulates oscillatory coupling between premotor and motor cortical areas in Parkinson's diseaseDamian Marc Herz, Esther Florin, Mark Schram Christensen, et al.
Pageof 152

Showing results (891-900 of 1,518) with videos related to

Sort By:
Pageof 152
Lung Cancer (Amsterdam, Netherlands)|October 24, 2013
A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancerMartin Reck, Maciej Krzakowski, Ewa Chmielowska, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2012
Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trialM Reck, I Bondarenko, A Luft, et al.
Lung Cancer (Amsterdam, Netherlands)|January 28, 2014
Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)N Reinmuth, A Meyer, D Hartwigsen, et al.
Nature Communications|April 29, 2022
Mitofusin 1 and 2 regulation of mitochondrial DNA content is a critical determinant of glucose homeostasisVaibhav Sidarala, Jie Zhu, Elena Levi-D'Ancona, et al.
Nature Structural & Molecular Biology|May 23, 2025
Multiple steps of dynein activation by Lis1 visualized by cryo-EMAgnieszka A Kendrick, Kendrick H V Nguyen, Wen Ma, et al.
Oncology|January 25, 2012
A phase II randomized study of cisplatin-pemetrexed plus either enzastaurin or placebo in chemonaive patients with advanced non-small cell lung cancerJohan Vansteenkiste, Rodryg Ramlau, Joachim von Pawel, et al.
Glycoconjugate Journal|June 1, 1995
Substrate specificity and inhibition of UDP-GlcNAc:GlcNAc beta 1-2Man alpha 1-6R beta 1,6-N-acetylglucosaminyltransferase V using synthetic substrate analoguesI Brockhausen, F Reck, W Kuhns, et al.
Clinical Lung Cancer|March 26, 2017
The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613Jordi Remon, Jessica Menis, Baktiar Hasan, et al.
Microorganisms|November 24, 2022
Bioremediation of Petroleum-Contaminated Soils with Biosurfactant-Producing Degraders Isolated from the Native Desert SoilsZheng Li, Ravid Rosenzweig, Fengxian Chen, et al.
Cerebral Cortex (New York, N.Y. : 1991)|June 5, 2013
Dopamine replacement modulates oscillatory coupling between premotor and motor cortical areas in Parkinson's diseaseDamian Marc Herz, Esther Florin, Mark Schram Christensen, et al.
Pageof 152